You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Leukemia

Showing 9126 - 9150 of 9,158
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Myeloid Leukemia Trial in Innsbruck (Imatinib)

Unknown status
  • Chronic Myeloid Leukemia
  • Innsbruck, Tyrol, Austria
    Medical University Innsbruck
Jun 16, 2006

Acute Myelogenous Leukemia Trial in United States (Mylotarg (gemtuzumab ozogamicin) Injection)

Completed
  • Acute Myelogenous Leukemia
  • Mylotarg (gemtuzumab ozogamicin) Injection
  • Little Rock, Arkansas
  • +12 more
May 17, 2006

Tumors Trial in Jerusalem (Cell therapy)

Unknown status
  • Tumors
  • Cell therapy
  • Jerusalem, Israel
    Hadassah Medical Organization
Mar 13, 2007

Solid Malignancies, Non-Hodgkin's Lymphoma Trial in Bronx, San Antonio (AQ4N)

Unknown status
  • Solid Malignancies
  • Non-Hodgkin's Lymphoma
  • Bronx, New York
  • +1 more
Oct 31, 2006

Multiple Myeloma Trial in Italy (THALIDOMIDE, BORTEZOMIB)

Completed
  • Multiple Myeloma
  • Bolzano, Italy
  • +6 more
Nov 30, 2006

Tumors Trial in Baltimore (Troxatyl™ (Cytotoxic Chemotherapeutic))

Terminated
  • Neoplasms
  • Troxatyl™ (Cytotoxic Chemotherapeutic)
  • Baltimore, Maryland
    The Sydney Kimmel Comprehensive Cancer Center at John Hopkins
Nov 1, 2006

Burkitt Lymphoma Trial in Villejuif (Rituximab)

Terminated
  • Burkitt Lymphoma
  • Villejuif, France
    Institut Gustave Roussy
Sep 7, 2006

Bone Marrow Angiogenesis in Acute Myeloid Leukemia - Evaluated

Unknown status
  • Acute Myeloid Leukemia
    • Taipei, Taiwan
      Tiffany Ting-Fang Shih
    Feb 28, 2006

    Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Berlin (WT1 126-134 peptide)

    Unknown status
    • Acute Myeloid Leukemia
    • Myelodysplastic Syndrome
    • WT1 126-134 peptide
    • Berlin, Germany
      Hematology&Oncology Charité CBF
    Feb 21, 2006

    Multiple Myeloma Trial in United States (Infusion of Activated & Expanded Autologous T Cells)

    Unknown status
    • Multiple Myeloma
    • Infusion of Activated & Expanded Autologous T Cells
    • Los Angeles, California
    • +5 more
    Nov 6, 2006

    GVHD Trial in Jerusalem (intra-arterial treatment)

    Completed
    • Graft vs Host Disease
    • intra-arterial treatment
    • Jerusalem, Israel
      Hadassah Medical Organization
    Nov 6, 2006

    Follicular Lymphoma Trial in Italy (rituximab, rituximab,fludarabine, cyclophosphamide)

    Completed
    • Follicular Lymphoma
    • rituximab
    • rituximab,fludarabine, cyclophosphamide
    • Arezzo, Italy
    • +8 more
    Oct 25, 2006

    Leukemia, Lymphocytic, Lymphoma Trial in Houston (BCX-1777)

    Completed
    • Leukemia, Lymphocytic
    • Lymphoma
    • Houston, Texas
      M.D. Anderson Cancer Center
    Jan 12, 2006

    Chronic Myeloid Leukemia Trial in Poitiers (Imatinib mesylate 400 mg)

    Completed
    • Chronic Myeloid Leukemia
    • Imatinib mesylate 400 mg
    • Poitiers, France
      University Hospital
    Dec 21, 2005

    Leukemia, Myeloid, Acute Trial in Créteil (Allogenic transplantation)

    Unknown status
    • Leukemia, Myeloid, Acute
    • Allogenic transplantation
    • Créteil, Val de Marne, France
      Henri Mondor Hospital
    Dec 13, 2005

    Chronic Myeloid Leukemia Trial in Poitiers (Imatinib mesylate 600 mg, Cytarabine, Daunorubicine)

    Terminated
    • Chronic Myeloid Leukemia
    • Imatinib mesylate 600 mg
    • +2 more
    • Poitiers, France
      University Hospital
    Nov 25, 2005

    De Novo Akute Myeloid Leukemia (AML), Secondary Acute Myeloid Leukemia (AML), Refractory Anemia With Excess of Blasts in

    Unknown status
    • De Novo Akute Myeloid Leukemia (AML)
    • +2 more
    • Hannover, Germany
      Hannover Medical School
    Nov 17, 2005

    Four Biological Parameters of Blast Cells in Adult Acute

    Unknown status
    • Adult Acute Lymphoblastic Leukemia
    • DNA Index
    • +3 more
    • Angers, France
      CRLCC Centre Paul Papin
    Oct 27, 2005

    Acute Myeloid Leukemia Trial in Frankfurt (Cytarabine, Etoposide, Idarubicin)

    Unknown status
    • Acute Myeloid Leukemia
    • Frankfurt, Germany
      University Hospital, Medical Department II
    Oct 25, 2005

    Significance of CXCR4-CXCL12 on Leukemic Cells Passing

    Unknown status
    • Acute Myelocytic Leukemia
    • Acute Lymphocytic Leukemia
      • Taipei, Taiwan
        Liang-In Lin
      Sep 9, 2005

      Leukemia, Lymphocytic, Chronic, Lymphoma, Small Lymphocytic Trial in New York (Pivanex)

      Terminated
      • Leukemia, Lymphocytic, Chronic
      • Lymphoma, Small Lymphocytic
      • New York, New York
        Center for Lymphoma and Myeloma; Weill Medical College of Cornel
      Aug 26, 2005

      WT1 Expressing Carcinoma Trial in Berlin (WT1 126-134 peptide)

      Unknown status
      • WT1 Expressing Carcinoma
      • WT1 126-134 peptide
      • Berlin, Germany
        Hem&Onc Charité CBF
      Feb 13, 2006

      Chronic Lymphocytic Leukemia Trial in United States (Nipent, Cytoxan, Rituxan)

      Unknown status
      • Chronic Lymphocytic Leukemia
      • Nipent, Cytoxan, Rituxan
      • Muscle Shoals, Alabama
      • +51 more
      Aug 17, 2005

      Fanconi's Anemia, MDS, Leukemia, Nonlymphocytic, Acute Trial in Minneapolis (cyclophosphamide, Allogeneic Bone Marrow

      Completed
      • Fanconi's Anemia
      • +3 more
      • Minneapolis, Minnesota
        Fairview University Medical Center
      Jun 23, 2005

      Chronic Lymphocytic Leukemia Trial in Palo Alto, New Hyde Park (Iodine-131 Anti-B1 Antibody)

      Unknown status
      • Chronic Lymphocytic Leukemia
      • Iodine-131 Anti-B1 Antibody
      • Palo Alto, California
      • +1 more
      Jun 23, 2005